Frontal balding is associated with a virilizing ovarian or adrenal tumor. Central obesity with a hip ratio of > 0.85 is associated with cardiovascular disease and is a marker for PCOS. A "buffalo ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

Perhaps PD-1 inhibitors just aren’t for ovarian cancer after all. | Merck's and GSK's similar overall survival setbacks ...

Every woman has a one in 87 chance of getting ovarian cancer in her lifetime, and one in 130 will die from it. The symptoms ...

Polycystic ovary syndrome is a common hormonal disorder that as many as five million women and people assigned female at ...

REBALANCE trial is a clinical trial exploring a minimally invasive device to induce ovulation and improve fertility in women ...

Acanthosis nigricans, a dark and hyperpigmented hyperplasia of the skin typically found at the nape of the neck and axilla, is a marker for insulin resistance. Acanthosis nigricans is usually ...

Influencers posing as medical experts are exploiting the lack of easy solutions for PCOS by selling fake cures.

New research has found that women who have had both ovaries surgically removed before the age of 50 and carry a variant of the apolipoprotein gene, the APOE4 allele, are at high risk of late-life ...

GSK has announced positive results from a phase III trial of its ovarian cancer treatment, which met its primary endpoint of ...

A study led by Roswell Park Comprehensive Cancer Center provides new insight into the complex interactions of the ...